Übersetzung für "Technological pharmaceutics " (Englisch → Französisch) :

Now, some research is subsidized by public monies, while other research is conducted by the private sector, in fields such as technology, pharmaceutical products, and so on.

The Working Group on Pharmaceuticals and Medical Devices which met in Seoul on 11 June 2015 discussed, inter alia, the Korean pharmaceuticals pricing system and the appropriate recognition of the value of innovative drugs and technologies, proposed amendments to the Korean National Health Insurance Act, implementation by Korea of serialisation for drugs, Korea's application for white-listing of Active Pharmaceutical Ingredients (APIs) in the EU, the reimbursement price cuts based on the import price methodology of medical devices, cli ...[+++]nical test requirements, and the proposed amendments to the EU medical device legislation related to the CE marking system.

The Community recognises the utmost desirability of promoting the transfer of technology and capacity-building to countries with insufficient or no manufacturing capacity in the pharmaceutical sector, in order to facilitate and increase the production of pharmaceutical products by those countries.

Innovative approaches in areas such as public transport, the organization of public space and the protection of borders can be envisaged. Space, offers great scope for high technology innovation over time (in particular public investors in the application of Galileo [17] and GMES (Global Monitoring for Environment and Security), the Commission's flagship space programmes. These need to share their knowledge of the system and its scope for business with potential downstream users in the space and non-space sectors, to raise their awareness of potential space-based solutions). Transport, where the demand for energy efficiency provides great opportunities. Marine technologies and produ ...[+++]cts allowing for new uses of the sea such as deep sea drilling, blue biotech exploitation, offshore mariculture and renewable energies, ocean space monitoring and surveillance technologies offer promising scope. Health, which has a huge growth potential for innovative products and services (including in particular e-Health, and the provision of customized solutions to allow elderly people to continue to live independently, pharmaceuticals and medical devices where innovation can bring direct benefits to patients and improve competitiveness), or well-being and culture (for instance creative content services, which gain a new dimension with the rollout of broadband networks, allowing citizens and businesses to access all kind of creative contents such as audiovisual, games, cultural information at home and in mobility) are examples of markets where the public sector has a role to play.

Money is an important component, because we are facing a tidal wave—it may be hitting us now—of new technology, pharmaceuticals, aging demographics, expectations, and a variety of these kinds of cost drivers that probably will determine some increase in funding.

Therefore, the demographic reality associated with investing in India over the long term — and I think that Canadian businesses do go into India decidedly with a medium-to long-term perspective — is that, for the foreseeable future, there will be an abundant supply of labour but also a market place with a growing middle class to be able to take advantage of an India that is transitioning toward a knowledge-based economy; particularly in information and communication technology, pharmaceuticals and so many other areas.